rs9391253

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000636060.1(LIN28B-AS1):​n.418+6843T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 151,824 control chromosomes in the GnomAD database, including 6,713 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6713 hom., cov: 31)

Consequence

LIN28B-AS1
ENST00000636060.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.506

Publications

27 publications found
Variant links:
Genes affected
LIN28B-AS1 (HGNC:21553): (LIN28B antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000636060.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.319 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000636060.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LIN28B-AS1
ENST00000636060.1
TSL:5
n.418+6843T>A
intron
N/A
LIN28B-AS1
ENST00000636951.1
TSL:5
n.458+6843T>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.294
AC:
44653
AN:
151706
Hom.:
6710
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.256
Gnomad AMI
AF:
0.194
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.282
Gnomad EAS
AF:
0.304
Gnomad SAS
AF:
0.271
Gnomad FIN
AF:
0.321
Gnomad MID
AF:
0.342
Gnomad NFE
AF:
0.322
Gnomad OTH
AF:
0.282
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.294
AC:
44667
AN:
151824
Hom.:
6713
Cov.:
31
AF XY:
0.296
AC XY:
21931
AN XY:
74184
show subpopulations
African (AFR)
AF:
0.256
AC:
10611
AN:
41412
American (AMR)
AF:
0.268
AC:
4074
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.282
AC:
979
AN:
3472
East Asian (EAS)
AF:
0.303
AC:
1563
AN:
5152
South Asian (SAS)
AF:
0.272
AC:
1304
AN:
4796
European-Finnish (FIN)
AF:
0.321
AC:
3378
AN:
10524
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.322
AC:
21892
AN:
67944
Other (OTH)
AF:
0.279
AC:
588
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1554
3109
4663
6218
7772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.308
Hom.:
911
Bravo
AF:
0.286
Asia WGS
AF:
0.262
AC:
917
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
8.5
DANN
Benign
0.77
PhyloP100
0.51

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs9391253;
hg19: chr6-105367616;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.